After years of shaping the content and conversations you check daily, Orthopedics This Week (OTW) Founder and Editor Emeritus Robin Young will take to the stage as the keynote speaker at the inaugural New York Spine Society Meeting (NYSS).
OTW Editor Robin Young Keynotes NYC Spine Society Meeting
1 min read Premium comments
Secondary#keynoter#nyss#robinyoung
NYSS, to be held October 24 in New York City, will bring together New York-based orthopedic and neurological spine surgeons. The free, but limited, event promises education, networking and collaboration in an “informal setting.”
During the keynote presentation, Young will present its State of Spine Companies and Technology Outlook.
The event will begin with a networking reception at 6:30 p.m. ET at the offices of Smith & Wollensky—on the second floor of 797 Third Ave—followed by the program and dinner.
The deadline to RSVP for the event is Oct. 9. Click this link to visit the RSVP page.
New York University’s Jeffrey Goldstein, M.D., organized the event. He is a clinical professor of orthopedic surgery and neurosurgery at NYU Grossman School of Medicine, as well as the director of spine service education and the spine surgery fellowship at NYU Langone Orthopedics.
About the Speaker
Robin Young is a subject matter expert within the orthopedics industry, having analyzed the field of spine surgery and reported on developments in orthopedics technology since he founded Orthopedics This Week (OTW). OTW is one of the most widely read sources of orthopedics news with more than 180,000 monthly readers.
Young was named “Best on the Street” by the Wall Street Journal and was identified as one of the top ten analysts in the United States by Institutional Investor Magazine.
He has authored more than 1,000 research reports and six books on subjects such as surgical biomaterial, the spinal implant industry and the stock market. He also hosted the New York Stem Cell Summit for nine years.
Prior to founding OTW, Young spent 25 years as a Wall Street medical technology analyst.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.